563 related articles for article (PubMed ID: 18825758)
1. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
3. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
[TBL] [Abstract][Full Text] [Related]
4. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
[TBL] [Abstract][Full Text] [Related]
5. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
6. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
7. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
8. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF
Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814
[TBL] [Abstract][Full Text] [Related]
9. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
10. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength.
Pierre VC; Botta M; Raymond KN
J Am Chem Soc; 2005 Jan; 127(2):504-5. PubMed ID: 15643857
[TBL] [Abstract][Full Text] [Related]
11. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands.
Pierre VC; Melchior M; Doble DM; Raymond KN
Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201
[TBL] [Abstract][Full Text] [Related]
12. A novel cholic acid-based contrast enhancement agent for targeted MRI.
Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
[TBL] [Abstract][Full Text] [Related]
13. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
14. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.
Datta A; Hooker JM; Botta M; Francis MB; Aime S; Raymond KN
J Am Chem Soc; 2008 Feb; 130(8):2546-52. PubMed ID: 18247608
[TBL] [Abstract][Full Text] [Related]
15. Next generation, high relaxivity gadolinium MRI agents.
Raymond KN; Pierre VC
Bioconjug Chem; 2005; 16(1):3-8. PubMed ID: 15656568
[No Abstract] [Full Text] [Related]
16. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
17. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.
Doble DM; Melchior M; O'Sullivan B; Siering C; Xu J; Pierre VC; Raymond KN
Inorg Chem; 2003 Aug; 42(16):4930-7. PubMed ID: 12895117
[TBL] [Abstract][Full Text] [Related]
18. Fast and easy access to efficient bifunctional chelators for MRI applications.
Gugliotta G; Botta M; Giovenzana GB; Tei L
Bioorg Med Chem Lett; 2009 Jul; 19(13):3442-4. PubMed ID: 19477128
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
20. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]